SciELO - Scientific Electronic Library Online

 
vol.25 número5Guías clínicas de la enfermedad de Chagas 2006: Parte V. Diagnóstico de laboratorioVaricela: Consultas frecuentes acerca de su tratamiento y el manejo de los contactos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista chilena de infectología

versão impressa ISSN 0716-1018

Resumo

APT B, Werner et al. Guidelines for the Chagas disease: Part VI. Antiparasitic treatment for Chagas disease. Rev. chil. infectol. [online]. 2008, vol.25, n.5, pp.384-389. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182008000500013.

As expert consensus has been arisen about universal antiparasitic treatment for all patients infected with Trypanosoma cruzi, most important drugs licensed for Chagas disease treatment are reviewed: nifurtimox and benznidazol, their mechanisms of action, doses, treatment schedules, adverse effects and contraindications. Two other drugs used for Chagas disease treatment, for which a Chilean experience may be exhibited, are allopurinol and itraconazole. Indications for treatment of Chagas disease in immunocompetent patients and inmunocompromised hosts are detailed. This chapter refers besides to the evaluation and monitoring of antiparasitic therapy in inmunocompromised patients, the availability of drugs and includes various forms facsímiles suggested to perform clinical and laboratory follow up of patients that undergo treatment, indicating the prescribed drug, adverse effects and time of follow up.

Palavras-chave : Chagas disease; American Trypanosomiasis; treatment.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons